These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 36380776)

  • 1. The many NOs to the use of Class IC antiarrhythmics: weren't the guidelines too strict?
    Turturiello D; Cappato R
    Eur Heart J Suppl; 2022 Nov; 24(Suppl I):I47-I53. PubMed ID: 36380776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are antiarrhythmic agents indicated in premature ventricular complex-induced cardiomyopathy and when?
    Kantharia BK; Shah AN
    J Cardiovasc Electrophysiol; 2024 Mar; 35(3):574-582. PubMed ID: 37676022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of class IC antiarrhythmic drugs in patients with structural heart disease and implantable cardioverter defibrillator.
    Zylla MM; Wolfes J; Schleberger R; Lawin D; Kieser M; Reinke F; Eckardt L; Rillig A; Stellbrink C; Thomas D; Frey N; Lugenbiel P
    Clin Res Cardiol; 2024 Jun; 113(6):933-941. PubMed ID: 38372753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease: the Prevention Investigation and Treatment: A Group for Observation and Research on Atrial arrhythmias (PITAGORA) trial.
    Gulizia M; Mangiameli S; Orazi S; Chiarandà G; Piccione G; Di Giovanni N; Colletti A; Pensabene O; Lisi F; Vasquez L; Grammatico A; Boriani G;
    Am Heart J; 2008 Jan; 155(1):100-7, 107.e1. PubMed ID: 18082498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flecainide in Ventricular Arrhythmias: From Old Myths to New Perspectives.
    Lavalle C; Trivigno S; Vetta G; Magnocavallo M; Mariani MV; Santini L; Forleo GB; Grimaldi M; Badagliacca R; Lanata L; Ricci RP
    J Clin Med; 2021 Aug; 10(16):. PubMed ID: 34441994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Class IC antiarrhythmic drugs for suspected premature ventricular contraction-induced cardiomyopathy.
    Hyman MC; Mustin D; Supple G; Schaller RD; Santangeli P; Arkles J; Lin D; Muser D; Dixit S; Nazarian S; Epstein AE; Callans DJ; Marchlinski FE; Frankel DS
    Heart Rhythm; 2018 Feb; 15(2):159-163. PubMed ID: 29405947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-treatment with antiarrhythmic drugs for elective electrical cardioversion of atrial fibrillation: a systematic review and network meta-analysis.
    Um KJ; McIntyre WF; Mendoza PA; Ibrahim O; Nguyen ST; Lin SH; Duceppe E; Rochwerg B; Healey JS; Koziarz A; Lengyel AP; Bhatnagar A; Amit G; Chu VA; Whitlock RP; Belley-Côté EP
    Europace; 2022 Oct; 24(10):1548-1559. PubMed ID: 35654763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
    Lafuente-Lafuente C; Valembois L; Bergmann JF; Belmin J
    Cochrane Database Syst Rev; 2015 Mar; (3):CD005049. PubMed ID: 25820938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
    Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
    Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and rationale of a randomized study to compare amiodarone and Class IC anti-arrhythmic drugs in terms of atrial fibrillation treatment efficacy in patients paced for sinus node disease: the PITAGORA trial.
    Gulizia M; Mangiameli S; Chiarandà G; Spadola V; Di Giovanni N; Colletti A; Bulla V; Circo A; Pensabene O; Vasquez L; Vaccaro I; Grammatico A;
    Europace; 2006 Apr; 8(4):302-5. PubMed ID: 16627459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
    Valembois L; Audureau E; Takeda A; Jarzebowski W; Belmin J; Lafuente-Lafuente C
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD005049. PubMed ID: 31483500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Flecainide for the Treatment of Atrial Fibrillation.
    Echt DS; Ruskin JN
    Am J Cardiol; 2020 Apr; 125(7):1123-1133. PubMed ID: 32044037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
    Lafuente-Lafuente C; Longas-Tejero MA; Bergmann JF; Belmin J
    Cochrane Database Syst Rev; 2012 May; (5):CD005049. PubMed ID: 22592700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
    Lafuente-Lafuente C; Mouly S; Longas-Tejero MA; Bergmann JF
    Cochrane Database Syst Rev; 2007 Oct; (4):CD005049. PubMed ID: 17943835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Class 1C Antiarrhythmics for Premature Ventricular Complex Suppression in Nonischemic Cardiomyopathy With Implantable Cardioverter-Defibrillators.
    Raad M; Yogasundaram H; Oranefo J; Guandalini G; Markman T; Hyman M; Schaller R; Supple G; Deo R; Nazarian S; Riley M; Lin D; Garcia F; Dixit S; Epstein AE; Callans D; Marchlinski FE; Frankel DS
    JACC Clin Electrophysiol; 2024 May; 10(5):846-853. PubMed ID: 38551548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of flecainide.
    Tamargo J; Capucci A; Mabo P
    Drug Saf; 2012 Apr; 35(4):273-89. PubMed ID: 22435343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maastricht antiarrhythmic drug evaluator (MANTA): A computational tool for better understanding of antiarrhythmic drugs.
    Sutanto H; Laudy L; Clerx M; Dobrev D; Crijns HJGM; Heijman J
    Pharmacol Res; 2019 Oct; 148():104444. PubMed ID: 31493513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral Class I and III antiarrhythmic drugs for maintaining sinus rhythm after catheter ablation of atrial fibrillation.
    Bray JJH; Warraich M; Whitfield MG; Peter CU; Baral R; Ahmad M; Ahmad S; Abraham GR; Kirresh A; Sahibzada MS; Muzaffar A; Tomson J; Lambiase PD; Captur G; Banerjee A; Providencia R
    Cochrane Database Syst Rev; 2023 Mar; 3(3):CD013765. PubMed ID: 36915032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS; Zehender M
    Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacologic treatment of atrial fibrillation.
    Bolognesi R
    Cardiovasc Drugs Ther; 1991 Jun; 5(3):617-28. PubMed ID: 1678964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.